# Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD

Study · id `cardio:ct-nct02502981` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02502981](<https://clinicaltrials.gov/study/NCT02502981>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02502981

Browse, organ or system: Heart; Kidneys  
Browse, condition area: Heart failure; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 154 participants.

## Technical summary

Registry record NCT02502981. Allocation not applicable; no masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2018-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 154 participants (enrolled count; ClinicalTrials.gov record NCT02502981, source copy `cardio:ctgov-nct02502981-2018-01-19`, retrieved 2026-10-26)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT02502981, source copy `cardio:ctgov-nct02502981-2018-01-19`, retrieved 2026-10-26)
- Primary completion: 2018-02 (anticipated) (ClinicalTrials.gov record NCT02502981, source copy `cardio:ctgov-nct02502981-2018-01-19`, retrieved 2026-10-26)
- Completion: 2018-05 (anticipated) (ClinicalTrials.gov record NCT02502981, source copy `cardio:ctgov-nct02502981-2018-01-19`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02502981, source copy `cardio:ctgov-nct02502981-2018-01-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02502981-2018-01-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
- Acronym: SPIRO-CKD
- Condition: Renal Insufficiency, Chronic
- Condition: Cardio-Renal Syndrome
- Intervention (Drug): Spironolactone
- Intervention (Drug): Chlortalidone
- Lead sponsor: University Hospital Birmingham
- Lead sponsor class: OTHER
- Collaborator: Royal Free Hospital NHS Foundation Trust
- Collaborator class: OTHER
- Collaborator: University of Edinburgh
- Collaborator class: OTHER
- Collaborator: University of Cambridge
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Chlorthalidone (`cardio:chlorthalidone`)
- Registry lists this organization as a collaborator: Royal Free Hospital NHS Foundation Trust (`cardio:org-royal-free-hospital-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: University of Cambridge (`cardio:org-university-of-cambridge`)

## Provenance

Content hash: a0c9904acb0291ad93de172d35d00363b2bd9356fb96d77e3ce9dc9fe2c23f44
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
